Reply to: intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis
Expert Opin Pharmacother
.
2023 May;24(7):873.
doi: 10.1080/14656566.2023.2203813.
Epub 2023 Apr 19.
Authors
Fiammetta Vanoli
1
2
,
Renato Mantegazza
1
Affiliations
1
Neuroimmunology and Neuromuscular Disease Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
2
Piazzale Aldo Moro 5, Department of Human Neurosciences Sapienza University of Rome, Rome, Italy.
PMID:
37057628
DOI:
10.1080/14656566.2023.2203813
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunoglobulins, Intravenous*
Myasthenia Gravis*
Substances
Immunoglobulins, Intravenous